ALLENA PHARMACEUTICALS, INC.
Profile
Company Names
ALLENA PHARMACEUTICALS, INC.
Addresses
ONE NEWTON EXECUTIVE PARK, SUITE 202, NEWTON, MA 02462
Phone Numbers
617-467-4577
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$80,494,545.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-05-04
$4,052,406.00
$4,052,406.00
$0.00
2
2015-11-25
$51,442,139.00
$53,000,000.00
$1,557,861.00
Equity
1
2014-10-29
$25,000,000.00
$27,000,000.00
$2,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
AXEL
BOLTE
DIRECTOR
LOUIS
BRENNER
EXECUTIVE OFFICER
MARK
FITZPATRICK
DIRECTOR
CRYSTAL CAPITAL FUND SERIES, LLC
| CRYSTAL CAPITAL MASTER FUND, LLC
| CRYSTAL CAPITAL INTERNATIONAL FUND SPC
| SURELINE SYSTEMS, INC.
| GLIDE FUND SERIES LLC
| PEACHJAR, INC.
| GLIDE FUND SPC LTD
| PSPIB LONGHORNS REIT LLC
| ALLENA PHARMACEUTICALS, INC.
| GLIDE DIRECT SERIES, LLC
| BLUE HERON SHORT-TERM INFRASTRUCTURE FUND
| BLUE HERON SHORT-TERM INFRASTRUCTURE QP FUND
| GLIDE PUERTO RICO SERIES LLC
STEPHEN
KRAUS
DIRECTOR
ALEXEY
MARGOLIN
EXECUTIVE OFFICER, DIRECTOR
GINO
SANTINI
DIRECTOR
ROBERT
TEPPER
DIRECTOR
CERULEAN PHARMA INC.
| ALNARA PHARMACEUTICALS INC
| CONSTELLATION PHARMACEUTICALS INC
| FOUNDATION MEDICINE, INC.
| KALA PHARMACEUTICALS, INC.
| BLUEBIRD BIO, INC.
| THIRD ROCK VENTURES III, L.P.
| ALLENA PHARMACEUTICALS, INC.
| JOUNCE THERAPEUTICS, INC.
| THIRD ROCK VENTURES IV, L.P.
| NEON THERAPEUTICS, INC.
| THIRD ROCK VENTURES V, L.P.
| FAZE MEDICINES, INC.
| THIRD ROCK VENTURES VI, L.P.
JAMES
TOPPER
DIRECTOR
CALISTOGA PHARMACEUTICALS INC
| INCLINE THERAPEUTICS, INC.
| PORTOLA PHARMACEUTICALS INC
| ATTEROCOR, INC.
| SEMNUR PHARMACEUTICALS, INC.
| PRONAI THERAPEUTICS INC
| ALLENA PHARMACEUTICALS, INC.
| CHANRX CORP.
| ANAPTYSBIO INC
| LAGUNA PHARMACEUTICALS, INC.
| ALPINE IMMUNE SCIENCES, INC.
| MERGANSER BIOTECH, INC.
| ALCRESTA, INC.
| ALCRESTA THERAPEUTICS, INC.
| MILLENDO THERAPEUTICS, INC.
| APTINYX INC.
| ALPINE IMMUNE SCIENCES, INC.
| AMUNIX PHARMACEUTICALS, INC.
| ENLAZA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2022-05-04
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

